The dosage of semaglutide for weight loss is personalized to each patient but often starts at a low dose, such as 0.25 mg once weekly, and may be gradually increased to a maximum of 2.4 mg once weekly based on the patients response and tolerability
Alternatively, microdosing can also be done by taking standard doses less frequently, at longer intervals
In vivo mouse studies at 20 mg/kg subcutaneous, three injections per day for 11 days, produced reductions in body weight, white adipose mass, and adipocyte size
Trial populations and endpoints varied across studies, and individual outcomes differ, whether the semaglutide dispensed is a branded product or a compounded formulation
A review of 2020 also suggests that Melanotan II can cause a renal infarction (13), which can be life-threatening at times
[DOI] [PubMed] [Google Scholar] 240.Ferruelo A., de Las Heras M.M., Redondo C., Ramn de Fata F., Romero I., Angulo J.C